Skip to main content
logo
NeoRich BioPharma Tech Co., Limited (PHBID)
OTCMKTS · Delayed Price · Currency is USD
0.3400
+0.0060 (1.80%)
At close: Aug 19, 2026

NeoRich BioPharma Tech Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.

Total Valuation

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Aug '26 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20
Market Capitalization
0304108
Market Cap Growth
-80.32%594.36%-90.92%-57.81%36.76%-94.87%
Enterprise Value
-315118
Last Close Price
0.348.401.4020.0055.00160.00

Price Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Aug '26 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20
PS Ratio
39.15817.39133.90---
PB Ratio
-0.05-0.89-0.18-2.43-6.19-2.61

EV Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Aug '26 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20
EV/Sales Ratio
-907.67249.79---

Financial Efficiency

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Aug '26 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20
Debt / Equity Ratio
-0.15-0.11-0.17-0.19-0.16-0.24
Net Debt / Equity Ratio
-0.15-0.11-0.17-0.18-0.14-0.24
Net Debt / FCF Ratio
-10.66-12.67-5.03-0.77-1.19-1.16
Asset Turnover
0.030.030.02---
Inventory Turnover
0.200.20----
Quick Ratio
0.0000.000.000.010.00
Current Ratio
0.040.000.020.110.180.08
Return on Assets (ROA)
-139.13%-141.50%-179.26%-229.74%-147.17%-67.73%
Return on Capital Employed (ROCE)
10.10%8.20%22.70%62.80%45.50%16.70%

Yields

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Aug '26 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20
Earnings Yield
-192.51%-36.04%-141.69%-19.80%-43.24%-31.81%
FCF Yield
-28.06%-1.01%-18.39%-9.64%-1.97%-7.93%
Buyback Yield / Dilution
-28.47%-41.33%-15.55%-37.46%-257.86%-10.81%